Amplifon (AMP) Stock Price, Fundamentals & Analysis

What AMP does

Amplifon (AMP) is a Healthcare sector company active in Medical Distribution, listed on Borsa Italiana. Headquartered in Milan, Italy, it employs 11,792 people and distributes hearing solutions together with the fitting of customized products designed to help people rediscover the emotions of sound. It operates Ampli-care, a platform that delivers an audiological care experience, and the Amplifon App, which lets users manage device functions in real time directly from a smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 1950 and serves regions across Europe, the Middle East, Africa, the Americas, and the Asia Pacific. Investors looking at other names in the space may also study peers such as Alcon Inc (ALC) or Recordati (REC), while those focused on the Italian exchange can compare it with Borsa Italiana stocks.

Key numbers explained

• At 11.43 EUR, Amplifon trades near the lower end of its 7.84 – 15.84 52-week range, and the share price is down -1.25% today and -18.2% over the last year.
• The P/E ratio on trailing earnings is 36.9, while the forward P/E on expected earnings is 13 — a gap that shows how much cheaper the stock looks if earnings recover.
• The dividend yield is 2.54%, with an ex-dividend date of May 18, 2026, and 93% of earnings is paid out as dividends.
• Market capitalization is 3.04B EUR, with trailing 12-month revenue of 2.4B EUR growing 2.2% year over year.
• Profit margin is 3%, operating margin 13.3%, and return on equity 5.7%, while the debt-to-equity ratio sits at 117.7%.
• The beta of 0.99 means the share has historically moved almost in line with the broader market.

What to watch

Hearing-care demand is shaped by demographics and consumer awareness, so shifts in either can affect a distributor like Amplifon. Competitive pressure from other medical-device and pharmaceutical players — such as Diasorin (DIA) in the Italian Healthcare space — can influence pricing and market share. Currency moves matter because the company operates across multiple continents. Leverage is another factor to monitor: a debt-to-equity ratio of 117.7% means financing costs can weigh on results if margins tighten. Finally, the next earnings date, Oct 29, 2026, will be a checkpoint for revenue growth and profitability trends.